|
GSR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.809800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.537200E-01 |
| Normal-vs-Stage2 |
7.834800E-01 |
| Normal-vs-Stage3 |
2.709200E-01 |
| Normal-vs-Stage4 |
4.231800E-01 |
| Stage1-vs-Stage2 |
7.238600E-01 |
| Stage1-vs-Stage3 |
6.467800E-01 |
| Stage1-vs-Stage4 |
9.074200E-01 |
| Stage2-vs-Stage3 |
5.041000E-01 |
| Stage2-vs-Stage4 |
6.668600E-01 |
| Stage3-vs-Stage4 |
8.112800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.086000E-01 |
| Normal-vs-AfricanAmerican |
1.635750E-01 |
| Normal-vs-Asian |
1.041180E-01 |
| Caucasian-vs-AfricanAmerican |
8.583900E-02 |
| Caucasian-vs-Asian |
3.652600E-01 |
| AfricanAmerican-vs-Asian |
1.245560E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.772200E-01 |
| Normal-vs-Female |
3.225000E-01 |
| Male-vs-Female |
8.252400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.204200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.527970E-01 |
| Normal-vs-Age(61-80Yrs) |
9.233600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.941900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.604600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.048600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.173800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.603800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.072600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.520100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.839630E-01 |
| Classical-VS-Follicular |
1.359760E-01 |
| Classical-VS-Other |
1.978640E-01 |
| Classical-VS-Normal |
8.306600E-01 |
| Tall-VS-Follicular |
9.554600E-01 |
| Tall-VS-Other |
2.272400E-01 |
| Tall-VS-Normal |
1.700010E-01 |
| Follicular-VS-Other |
3.192200E-01 |
| Follicular-VS-Normal |
1.402250E-01 |
| Other-VS-Normal |
3.533600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.083900E-02 |
| Normal-vs-N1 |
3.428200E-02 |
| N0-vs-N1 |
3.178400E-01 |
|
|
